{{Refimprove|date=September 2014}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 407835535
| IUPAC_name = 2-(2,6-dichlorobenzylidene)hydrazinecarboximidamide
| image = Guanabenz.svg
| image2 = Guanabenz_sf.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CDI|guanabenz}}
| MedlinePlus = a686003
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
<!--Pharmacokinetic data-->
| protein_bound = 90%
| elimination_half-life = 6 hours
<!--Identifiers-->
| IUPHAR_ligand = 5443
| CAS_number = 5051-62-7
| ATC_prefix = none
| PubChem = 5702063
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00629
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4642445
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = GGD30112WC
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04375
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 420
<!--Chemical data-->
| C=8 | H=8 | Cl=2 | N=4
| molecular_weight = 231.081 g/mol
| smiles = Clc1cccc(Cl)c1\C=N\N=C(/N)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WDZVGELJXXEGPV-YIXHJXPBSA-N
}}
'''Guanabenz''' (pronounced GWAHN-a-benz, sold under the trade name '''Wytensin''') is an [[Alpha-adrenergic agonist|alpha agonist]] of the [[alpha-2 adrenergic receptor]] that is used as an [[antihypertensive]] drug. It is used to treat high blood pressure ([[hypertension]]).<ref>{{cite journal |title = Comparative antihypertensive effects of guanabenz and clonidine |pmid = 7037502 |vauthors=Walker BR, Hare LE, Deitch MW |journal = The Journal of International Medical Research |year = 1982 |volume = 10 |pages = 6â€“14 |url = http://ukpmc.ac.uk/abstract/MED/7037502}}</ref><ref>{{cite journal |title = Studies on the mechanism of the central antihypertensive effect of guanabenz and clonidine |vauthors=Bonham AC, Trapani AJ, Portis LR, Brody MJ |journal = Journal of Hypertension Supplement |year = 1984 |volume = 2 |pages =S543-6 |url = http://ukpmc.ac.uk/abstract/MED/6599714}}</ref>

The most common side effects during guanabenz therapy are [[dizziness]], [[drowsiness]], [[dry mouth]], [[headache]] and [[weakness]].

Guanabenz can make one drowsy or less alert, therefore driving or operating dangerous machinery is not recommended.

==See also==
*[[Guanoxabenz]]
*[[Guanfacine]]

== References ==
{{reflist|2}}

{{Adrenergic agonists}}
{{Antihypertensives and diuretics}}

[[Category:Guanidines]]
[[Category:Alpha-adrenergic agonists]]
[[Category:Chloroarenes]]


{{Antihypertensive-stub}}